CVS Caremark (CVS) Stock Research, Analysis & News

Quick Analysis on CVS Caremark (CVS) Stock as of July 28, 2017

Previous Closing Price $78.92 is above 50 day moving average of $78.71
Previous Closing Price $78.92 is below its 200 day moving average $79.20
The Price/Earnings To Growth ratio (PEG) is great than 1
The Stock pays a dividend of 2.53%
The closing price $78.92 is less than 10.45% away from its one year target price of $87.17
Good Price to Sale Ratio 0.45
Current Short Ratio 3.89 is great than 1
(See more information about CVS Caremark (CVS) Stock below)

CVS Caremark (CVS) Stock Profile Summary

CVS Caremark Corporation operates as a pharmacy services company in the United States. It operates in two segments, Pharmacy Services and Retail Pharmacy. The Pharmacy Service segment provides a range of prescription benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing. This segment primarily serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals. As of December 31, 2009, it operated 49 retail specialty pharmacy stores, 18 specialty mail order pharmacies, and 6 mail service pharmacies located in 25 states, Puerto Rico, and the District of Columbia. This segment operates business under the Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica, AccordantCare, and TheraCom names. The Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its pharmacy retail stores and online. It also provides health care services. This segment operated 7,025 retail drugstores located in 41 states and the District of Columbia; and 569 retail health care clinics in 25 states. The company has a strategic alliance with Alere, L.L.C. for the management of disease management program offerings that cover chronic diseases, such as asthma, diabetes, congestive heart failure, and coronary artery disease. CVS Caremark Corporation was founded in 1892 and is based in Woonsocket, Rhode Island.

CVS Caremark (CVS) Stock Key Statistics Research and Analysis as of July 28, 2017

Stock ExchangeNYQ
Market Capitalization$80.51B
Trade Volume (Average Trading Volume)574,787 (6,143,120)
Price/Sales0.45
Price/Book2.40
P/E16.48
Earning/Share$4.80
Current Year EPS Estimate$5.87
Next Year EPS Estimate$6.39
Previous Closing Price$78.92
50 Day Price Moving Average$78.71
200 Day Price Moving Average$79.20
Dividend Yield2.53%
1 yr Target Price$87.17
Ex-Dividend Date7/20/2017
PEG Ratio1.66
Short Ratio3.89
EBITDA$12.81B

CVS Caremark (CVS) Stock Competitor Research and Analysis

Rite Aid Corp. (RAD)Walgreen Co. (WAG)
Wal-Mart Stores Inc. (WMT)

Mutual Funds with CVS Caremark (CVS) Stock in its top 10 holdings

FundCategoryCVS Holding Percentage
Alpine Accelerating Dividend InstlLarge Blend2.49%
Thrivent Large Cap Value ALarge Value3.6%
AB Large Cap Growth RLarge Growth2.78%
American Century Legacy Foc Lg Cap RLarge Blend2.82%

ETFs with CVS Caremark (CVS) Stock in its top 10 holdings

Stock Research on CVS Caremark (CVS)

Latest Market News on CVS Caremark (CVS)


Click here to find the latest news on CVS Caremark (CVS)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Rite Aid Corp. (RAD)
Walgreen Co. (WAG)
Wal-Mart Stores Inc. (WMT)